Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes

Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes

João Coelho1, Luísa Malheiro1, João Melo Beirão1,2, Angelina Meireles1,2, Bernardete Pessoa1,2 1Unit of Ophthalmology, Centro Hospitalar Universitário Do Porto, Porto, Portugal; 2Unit of Ophthalmology, Universidade Do Porto-Instituto Ci&ecir...

Full description

Bibliographic Details
Main Authors:	Coelho J, Malheiro L, Melo Beirão J, Meireles A, Pessoa B
Format:	Article
Language:	English
Published:	Dove Medical Press 2019-09-01
Series:	Clinical Ophthalmology
Subjects:	diabetic macular edema fluocinolone acetonide dexamethasone implant intravitreal implants real-world vitrectomy
Online Access:	https://www.dovepress.com/real-world-retrospective-comparison-of-019-mg-fluocinolone-acetonide-a-peer-reviewed-article-OPTH

Similar Items

Treatment of refractory diabetic macular edema with a fluocinolone acetonide implant in vitrectomized and non-vitrectomized eyes
by: Alberto La Mantia, et al.
Published: (2018-12-01)

Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant
by: Stéphanie Baillif, et al.
Published: (2022-11-01)

Rapid Structural and Functional Improvements with the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Patients with DME and Low Visual Acuity: 6-Month Data from the UAE
by: Elbarky AM
Published: (2020-03-01)

Intravitreal Fluocinolone Acetonide 0.19 mg Implant in a Patient with Resistant Blau Syndrome: A Case Report
by: Khushi Saigal, et al.
Published: (2024-01-01)

Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
by: William Fusi-Rubiano, et al.
Published: (2018-09-01)

Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years
by: William Fusi-Rubiano, et al.
Published: (2018-02-01)

Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis
by: Jong G. Park, et al.
Published: (2020-09-01)

Challenging Clinical Cases – A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN®)
by: Pessoa B, et al.
Published: (2020-09-01)

Scleral fixation of fluocinolone acetonide implant
by: Homayoun Tabandeh, et al.
Published: (2020-09-01)

Biomarkers to Predict the Success of Treatment with the Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Uveitic Macular Edema
by: Lucy Joanne Kessler, et al.
Published: (2022-03-01)

Efficacy and Safety of Fluocinolone Acetonide Implant in Diabetic Macular Edema: Practical Guidelines from Reference Center
by: Lucas Sejournet, et al.
Published: (2024-09-01)

Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study
by: Massin P, et al.
Published: (2016-07-01)

A Meta-Analysis of the Efficacy and Safety of the 0.19 mg Fluocinolone Acetonide Implant in Non-Infectious Uveitis
by: Suji Yeo, et al.
Published: (2025-01-01)

Fluocinolone acetonide intravitreal implant as a therapeutic option for severe Sjögren’s syndrome-related keratopathy: a case report
by: Joanna Wasielica-Poslednik, et al.
Published: (2019-01-01)

Long-Acting Fluocinolone Acetonide Intravitreal Implant for Recurrent Bilateral Non-Infectious Posterior Uveitis
by: Babel AT, et al.
Published: (2022-11-01)

Migration of a fluocinolone acetonide implant (Yutiq) to the anterior chamber and its nonurgent removal
by: Hamidah Mahmud, et al.
Published: (2020-12-01)

Ahmed glaucoma valve in uveitic patients with fluocinolone acetonide implant-induced glaucoma: 3-year follow-up
by: Kubaisi B, et al.
Published: (2018-05-01)

Efficacy and Safety of Intravitreal Fluocinolone Acetonide Implant for Chronic Diabetic Macular Edema Previously Treated in Real-Life Practice: The REALFAc Study
by: Thibaud Mathis, et al.
Published: (2022-03-01)

The USER Study: A Chart Review of Patients Receiving a 0.2 µg/day Fluocinolone Acetonide Implant for Diabetic Macular Edema
by: Alexander Eaton, et al.
Published: (2018-12-01)

Fluocinolone acetonide 0.18-mg implant for treatment of recurrent inflammation due to non-infectious uveitis: a case series of 15 patients
by: Robert A. Sisk, et al.
Published: (2024-09-01)

The effectiveness of the 0.19 mg fluocinolone acetonide implant in treating non-infectious posterior uveitis: a real-world experience
by: Igor Kozak, et al.
Published: (2024-06-01)

Evaluating the Safety, Efficacy and Patient Acceptability of Intravitreal Fluocinolone Acetonide (0.2mcg/Day) Implant in the Treatment of Non-Infectious Uveitis Affecting the Posterior Segment
by: Steeples LR, et al.
Published: (2021-04-01)

Fluocinolone acetonide implant scleral fixation for cystoid macular edema in eyes with iris–lens diaphragm disruption
by: Rita Costa Basto, et al.
Published: (2024-01-01)

Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Diabetic Macular Oedema: the ILUVI1MOIS Study
by: Nicolas Rousseau, et al.
Published: (2023-06-01)

Preserflo Microshunt Surgery for Ocular Hypertension following Intravitreal Fluocinolone Acetonide Implant Removal: A Case Report
by: Amina Rezkallah, et al.
Published: (2022-12-01)

Clinical Effectiveness of Intravitreal Fluocinolone Acetonide (FAc) (ILUVIEN™) in Patients with Diabetic Macular Oedema (DMO) Refractory to Prior Therapy: The Manchester Experience
by: James F. Young, et al.
Published: (2019-07-01)

Intraocular Pressure Changes Are Predictive of Ocular Hypertension Onset After Fluocinolone Acetonide Implant: Significant Cutoffs and the Role of Previous DEX Implant
by: Alessandro Arrigo, et al.
Published: (2021-08-01)

Fluocinolone Acetonide Implant for Uveitis: Dissecting Responder and Non-Responder Outcomes at a Tertiary Center
by: Jasmin Abu Arif, et al.
Published: (2024-05-01)

Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis
by: Zarranz-Ventura J, et al.
Published: (2020-06-01)

Cost-Effectiveness Analysis of Fluocinolone Acetonide Intravitreal (FAI) Implant for Chronic Noninfectious Uveitis Affecting the Posterior Segment of the Eye (NIU-PS) in China
by: Xin Mao, et al.
Published: (2024-04-01)

Comment on ’Effectiveness of 190 μg Fluocinolone Acetonide versus 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis’ [Response to Letter]
by: Zarranz-Ventura J, et al.
Published: (2020-11-01)

Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations
by: Uwe Pleyer, et al.
Published: (2024-05-01)

Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN®) and Follow-Up Considerations/Recommendations
by: Adán A, et al.
Published: (2020-07-01)

Clinical utility of intravitreal fluocinolone acetonide (Iluvien®) implant in the management of patients with chronic diabetic macular edema: a review of the current literature
by: Saedon H, et al.
Published: (2017-03-01)

Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME)
by: McCluskey JD, et al.
Published: (2019-04-01)

Corticosteroid Treatment in Diabetic Macular Edema
by: Burcu Nurözler Tabakcı, et al.
Published: (2017-06-01)

Achieving Quiescence with Fluocinolone Implants
by: Freia McGregor, et al.
Published: (2021-05-01)

Characterization of Transcriptomic and Proteomic Changes in the Skin after Chronic Fluocinolone Acetonide Treatment
by: Yongsu Choi, et al.
Published: (2022-12-01)

Fluocinolone intravitreal implant (Iluvien) for macular edema secondary to immune recovery uveitis in patient with acute myeloid leukemia
by: JM Cachero Rodríguez, et al.
Published: (2024-05-01)

Investigation of Solvolysis Kinetics of New Synthesized Fluocinolone Acetonide C-21 Esters—An In Vitro Model for Prodrug Activation
by: Katarina D. Karljikovic-Rajic, et al.
Published: (2011-03-01)